Ilika to showcase Stereax batteries to medical device manufacturers

Ilika Plc

Ilika’s Stereax solid state batteries will be represented at Medical Technology Ireland 2026, giving the company direct exposure to medical device manufacturers, suppliers and engineers.

The event takes place at Galway Racecourse on 23rd and 24th September 2026 and is focused on medical device design and manufacturing. Ilika is continuing to put its miniature battery technology in front of a market where small, reliable power sources are highly relevant.

Stereax batteries are designed for compact applications, including medical devices. In this market, battery size, reliability and ease of integration can be important factors when companies are developing next-generation products. Ilika’s presence at the event, through Cirtec Medical, helps keep the technology visible to the people involved in designing and producing those devices.

Product development cycles can be long, and customers typically need confidence in performance, manufacturing quality and supply before adopting new components. Regular engagement with the sector helps Ilika stay connected to potential customers and partners while the market continues to assess suitable battery solutions.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika advances Goliath towards commercial deployment

Ilika is advancing Goliath through testing and manufacturing scale-up while targeting shorter-cycle markets alongside longer-term electric vehicle adoption.

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.

Search